Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury.
Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series.
Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis.
Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.
"Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
Is neuropsychological rehabilitation effective in multiple sclerosis?
Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis.
Two cases of multiple sclerosis manifesting after in vitro fertilization procedures.
Role of glial 14-3-3 gamma protein in autoimmune demyelination.
Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology.
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis.
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course.
Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out.
Molecular mechanisms of scar-sourced axon growth inhibitors.
Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis.
Endothelin-B Receptor Activation in Astrocytes Regulates the Rate of Oligodendrocyte Regeneration during Remyelination.
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures.
Helminth Products Protect against Autoimmunity via Innate Type 2 Cytokines IL-5 and IL-33, Which Promote Eosinophilia.
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.
Presymptomatic and longitudinal neuroimaging in neurodegeneration-from snapshots to motion picture: a systematic review.
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.
[The cost-effectiveness of interferon beta treatment in patients with a clinically isolated syndrome in Colombia].
Pages
« first
‹ previous
…
551
552
553
554
555
556
557
558
559
…
next ›
last »